SureTrader
Home > Boards > US Listed > Biotechs >

Anthera Pharmaceuticals, Inc. (ANTH)

ANTH RSS Feed
Add ANTH Price Alert      Hide Sticky   Hide Intro
Moderator: bigarow
Search This Board: 
Last Post: 4/20/2018 9:49:35 AM - Followers: 77 - Board type: Free - Posts Today: 0


 


 Anthera Pharmaceuticals Inc.     


                                              Nasdaq: ANTH


 

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company has two product candidates in development.

 

Sollpura is Anthera’s novel biotechnology-derived pancreatic enzyme replacement therapy for the potential treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

Blisibimod is Anthera’s BAFF inhibitor for the potential treatment of systemic lupus erythematosus and IgA nephropathy.


Pipeline



                            Contact Info                                                                           
                                                                           

Anthera Pharmaceuticals, Inc. 

25801 Industrial Blvd, Suite B • Hayward, CA 94545



Press Contact: pr@anthera.com


Business Development: bd@anthera.com


 Vendors: ap@anthera.com


 Website: www.anthera.com

 

------>>Latest Developments<<-----

December 06, 2016

J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...

1
 
         
___________________________________________________________________________________________________________________________________________
Outstanding Share Data
October 31 ,2016,the Company had 41,955,126 common shares issued and outstanding
July 31,2016 the Company had 41,427,352 common shares issued and outstanding
April 27,2016 the Company had 40,987,145 common shares issued and outstanding
February 29,2016 the Company had 40,004,037 common shares issued and outstanding
November 1,2015 the Company had 39,875,405 common shares issued and outstanding
August 1,2015 the Company had 39,703,998 common shares issued and outstanding
May 1,2015 the Company had 35,816,364 common shares issued and outstanding
February 28,2015 the Company had 29,091,773 common shares issued and outstanding
November 10,2014 the Company had 22,939,553 common shares issued and outstanding
____________________________________________________________________________________________________________________________________________

MAJOR HOLDERS

 

68% of the outstanding owned by these longs

Outstanding 42mil minus Major ownership of 28.5mil = 13.5mil free trading float


28.5mil Major Holders in this,15mil Institutions,7.5mil Direct Holders,6mil Mutual Funds= 68% of 42mil os 


http://www.barrons.com/quote/stock/us/xnas/anth?mod=DNH_S

________________________________________________________________


http://finance.yahoo.com/q?s=ANTH

   Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation,

including cardiovascular and autoimmune diseases. We currently have a Phase 2 clinical program, blisibimod.It was just recently approved by FDA to move into

PHASE 3

 

   Blisibimod targets elevated levels of B-cell activating factor (BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren's Syndrome, Graves' Disease and others.


  It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab),

now marketed by GlaxoSmithKline and Human Genome Sciences, is the first human monoclonal antibody for the treatment

of lupus.




  Benlysta had a slow take-off grossing $59.2 million in sales in the last three quarters of 2011, but it was approved in numerous

countries by year's end.
Estimated sales for Benlysta in 2012 are said to be about $230 million, with first annual profits likely by 2015.


  The surprisingly slow uptake of Benlysta allows for blisibimod to develop into a promising drug as

it currently has more desirable features than that of Benlysta.


Blisibimod has a dosing regimen of one injection weekly, compared to that of Benlysta which requires a

series of dosing before the maintenance dose begins. Also, Benlysta has limitations on usage pertaining to

specific patient populations and has not been studied in combination with other biologics.

These attributes of blisibimod including a different mechanism of action, will set it apart from

Benlysta, Global Data concludes.

 

 

SureTrader
ANTH
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ANTH News: Current Report Filing (8-k) 04/16/2018 05:27:58 PM
ANTH News: Notice of Effectiveness (effect) 03/28/2018 06:01:41 AM
ANTH News: Current Report Filing (8-k) 03/12/2018 05:03:20 PM
ANTH News: Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference 03/07/2018 08:30:00 AM
ANTH News: Securities Registration Statement (simplified Form) (s-3) 03/06/2018 05:31:55 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2378   Surprising Stocks – Anthera Pharmaceuticals, Inc., NASDAQ: ANTH) DFRANK1970 04/20/18 09:49:35 AM
#2377   Attention to the volume of today ... pennystock_es 04/19/18 12:40:13 PM
#2376   I have my jeopardy music playing softly in DFRANK1970 04/17/18 12:19:34 PM
#2375   Total 1,472,200 Shorted shares which will generate huge Value_Investor 04/16/18 10:59:15 AM
#2374   Short Interest ... tic tac ... pennystock_es 04/16/18 09:22:33 AM
#2373   premarket Last: $ 0.38 ? 0.02 (6.73%) pennystock_es 04/13/18 08:10:55 AM
#2372   Great info there, but hindsight is always 20/20 brojazzy 04/10/18 02:31:04 PM
#2371   Not at all! ANTH had already crashed another Value_Investor 04/06/18 05:25:05 PM
#2370   No. It only bounced 42.5% from $0.40 to Value_Investor 04/06/18 05:20:51 PM
#2369   $0.57 was the Top ceiling price since the Value_Investor 04/06/18 05:17:17 PM
#2368   Anthera Pharmaceuticals, Inc. plans to evaluate all strategic Value_Investor 04/06/18 05:14:24 PM
#2367   Yes, chart was due for small bounce. IMO investor86 04/06/18 03:38:09 PM
#2366   You're possibly correct. Although the charts were correct Whos_Who 04/06/18 01:14:15 PM
#2365   No catalyst at all. Dead money. investor86 04/03/18 10:24:52 PM
#2364   Started a position here based merely on charts. Whos_Who 04/03/18 09:39:24 PM
#2363   can this company sustain itself ? and is profittrader00 03/27/18 11:59:43 AM
#2362   tic toc tic toc looking steez 03/27/18 10:32:27 AM
#2361   hold on tight ladies and gents, we go parabolic. aristotelisonassis 03/27/18 10:25:13 AM
#2359   Dr. Christopher Henney, currently Anthera Pharmaceuticals (A Trend-Setter 03/22/18 02:16:51 PM
#2357   this is the time dudes , going up jpowellvlc 03/21/18 03:46:09 PM
#2356   Looks very good from here , just got Slinging it 03/21/18 03:31:35 PM
#2355   Booommmm steez 03/21/18 02:27:02 PM
#2354   Looking good now. Tic toc. steez 03/21/18 01:55:34 PM
#2353   .328 here neslugger11 03/21/18 01:46:24 PM
#2352   No money, no pipeline, no income? willlbone 03/20/18 02:28:19 PM
#2351   starter position here @ 0,355 , good luck dudes!!!!! jpowellvlc 03/19/18 03:35:46 PM
#2350   0,35,,,near 0,3 could be a good trade jpowellvlc 03/19/18 01:51:03 PM
#2349   its equal than aker,,going down the first candle jpowellvlc 03/16/18 03:22:19 PM
#2348   I'm down more than 20%, not looking good. SilverNick 03/16/18 03:19:41 PM
#2347   going down 0,4, lets see next week what jpowellvlc 03/16/18 03:18:16 PM
#2346   Could but I doubt that. It bottomed SilverNick 03/14/18 11:01:15 AM
#2345   or this can see red to low 30's yiannisf 03/14/18 09:12:01 AM
#2344   Alright, now that we have had a whole SilverNick 03/13/18 02:57:42 PM
#2343   i hope you are right. i got a roni1 03/12/18 06:25:23 PM
#2342   I've been through this a ton of times, SilverNick 03/12/18 06:04:28 PM
#2341   3.00 huh? lmao power_forward 03/12/18 05:08:56 PM
#2340   Got in big time. .49. steez 03/12/18 04:57:46 PM
#2339   Count me in the .. buying at .50 G3TCRUNK3R 03/12/18 04:51:18 PM
#2338   Rebounce back Agserina 03/12/18 04:46:04 PM
#2337   Thanks for quick reply. roni1 03/12/18 02:39:02 PM
#2336   They ususally bounce back in upto 2 weeks. SilverNick 03/12/18 02:29:46 PM
#2335   i got in today at 0.5 for the roni1 03/12/18 02:08:06 PM
#2334   These biotechs ususally bounce the 2nd or third SilverNick 03/12/18 01:56:00 PM
#2333   Today sucks big time. investor86 03/12/18 01:52:47 PM
#2332   There's No Joy In Mudville. bigarow 03/12/18 01:50:43 PM
#2331   Bad drug trial MinkWhale 03/12/18 11:21:31 AM
#2330   Mon Mar 12 08:00:12 2018 EDT blukky 03/12/18 11:07:49 AM
#2329   What is going on here investor86 03/12/18 10:57:48 AM
#2328   WTFHappened here scary larry 03/12/18 09:59:45 AM
#2327   Gonna be hard to come back up now MinkWhale 03/12/18 09:57:23 AM
PostSubject